Trade VBIO anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Valion Bio, Inc. (VBIO) is trading at US$0.13, up 3.59% today as of Aug 28, 12:05 EDT. The company has a market capitalisation of US$508.94K. Over the past 52 weeks, VBIO has traded between US$0.11 and US$3.21. On Syfe you can trade VBIO with $0 commission and add it to your watchlist.
| Previous close | US$0.12 |
|---|---|
| Market cap | US$508.94K |
| 52-week range | US$0.11 – US$3.21 |
| Volume | 7.8M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Valion Bio, Inc.
Valion Bio, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company was founded by Jennifer Ernst and John Claude on September 22, 2016 and is headquartered in San Antonio, TX.
Year: 2021
Valion Bio's Entolimod Accepted for Regulatory Review in Ukraine
Jul 22, 12:33 PM · MT Newswires
Valion Bio Advances Entolimod Program with Government Engagement, Manufacturing Scale-Up, Oncology Supportive Care Plans
Jul 14, 12:35 PM · MT Newswires
Valion Bio, Inc. (VBIO) stock is trading at US$0.13, +3.59% from the previous close of US$0.12.
The market cap for Valion Bio, Inc. (VBIO) stock is approximately US$508.94K.
The 52-week high for Valion Bio, Inc. (VBIO) stock is US$3.21.
The 52-week low for Valion Bio, Inc. (VBIO) stock is US$0.11.
Valion Bio, Inc. (VBIO) does not currently pay a dividend.
Stay on top of VBIO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
